Systemic immune–inflammation index as a useful prognostic indicator predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy

BACKGROUND AND OBJECTIVE: A novel systemic immune–inflammation index named SII (SII=N×P/L), which is based on neutrophil (N), platelet (P) and lymphocyte (L) counts, has emerged and reflects comprehensively the balance of host inflammatory and immune status. We aimed to evaluate the potential progno...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Li, Yan, Ying, Zhu, Lihua, Cong, Xiliang, Li, Sen, Song, Shubin, Song, Hongjiang, Xue, Yingwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733921/
https://www.ncbi.nlm.nih.gov/pubmed/29276407
http://dx.doi.org/10.2147/CMAR.S151026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733921/
https://www.ncbi.nlm.nih.gov/pubmed/29276407
http://dx.doi.org/10.2147/CMAR.S151026

Ejemplares similares